Annual Drug Patent Expirations for ARMONAIR+RESPICLICK
Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are seventeen patents protecting this drug.
Drug patent litigation for ARMONAIR RESPICLICK.
This drug has three hundred and twenty-two patent family members in thirty-four countries.
The generic ingredient in ARMONAIR RESPICLICK is fluticasone propionate. One supplier is listed for this compound. Additional details are available on the fluticasone propionate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
